Coloplast A/S (CLPBF) Stock Price, News & Analysis

Company Overview

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Key Stats

• Today's Range: $111.33 to $111.33
• 50-Day Range: $105.50 to $132.48
• 52-Week Range: $104.75 to $143.15
• Volume: 3 shs
• Average Volume: 134 shs
• Market Capitalization: N/A
• P/E Ratio: 9.75
• Dividend Yield: 6.74%
• Price Target: N/A
• Consensus Rating: N/A

Coloplast A/S Stock Analysis - MarketRank™

Coloplast A/S scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Coloplast A/S.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Coloplast A/S is 9.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.77.

Price to Earnings Ratio vs. Sector

The P/E ratio of Coloplast A/S is 9.75, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.83.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Coloplast A/S has a short interest ratio ("days to cover") of 8034, which indicates bearish sentiment.

Change versus previous month

Short interest in Coloplast A/S has recently decreased by 4.97%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Coloplast A/S pays a meaningful dividend of 1.54%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Coloplast A/S does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Coloplast A/S is 65.69%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Coloplast A/S has a short interest ratio ("days to cover") of 8034, which indicates bearish sentiment.

Change versus previous month

Short interest in Coloplast A/S has recently decreased by 4.97%, indicating that investor sentiment is improving.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Coloplast A/S this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Coloplast A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 15.14% of the stock of Coloplast A/S is held by institutions.

CLPBF Stock Analysis - Frequently Asked Questions

How have CLPBF shares performed this year?

Coloplast A/S's stock was trading at $108.2810 at the beginning of 2025. Since then, CLPBF shares have increased by 2.8% and is now trading at $111.3250.
View the best growth stocks for 2025 here.

How do I buy shares of Coloplast A/S?

Shares of CLPBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 1/21/2025
• Next Earnings (Estimated): 2/04/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CLPBF
• CUSIP: N/A
• CIK: 1294325
• Web: www.coloplast.com
• Phone: (454) 911-1111
• Fax: N/A
• Employees: 15,930
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 9.75
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A